GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (MEX:AGIO) » Definitions » Forward Dividend Yield %

Agios Pharmaceuticals (MEX:AGIO) Forward Dividend Yield % : 0.00% (As of Jun. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Agios Pharmaceuticals Forward Dividend Yield %?

As of today (2024-06-25), the Forward Annual Dividend Yield of Agios Pharmaceuticals is 0.00%.

As of today (2024-06-25), the Trailing Annual Dividend Yield of Agios Pharmaceuticals is 0.00%.

MEX:AGIO's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.62
* Ranked among companies with meaningful Forward Dividend Yield % only.

Agios Pharmaceuticals's Dividends per Share for the three months ended in Mar. 2024 was MXN0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Agios Pharmaceuticals's Forward Dividend Yield %

For the Biotechnology subindustry, Agios Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agios Pharmaceuticals's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agios Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Agios Pharmaceuticals's Forward Dividend Yield % falls into.



Agios Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Agios Pharmaceuticals  (MEX:AGIO) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Agios Pharmaceuticals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Agios Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Agios Pharmaceuticals (MEX:AGIO) Business Description

Traded in Other Exchanges
Address
88 Sidney Street, Cambridge, MA, USA, 02139
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Agios Pharmaceuticals (MEX:AGIO) Headlines

From GuruFocus

Agios Appoints Jeffrey Capello to Board of Directors

By sperokesalga sperokesalga 04-19-2023